In vitro activity of trovafloxacin against Chlamydia pneumoniae.

Roblin, P M; Kutlin, A; Hammerschlag, M R

Name:

aac.41.9.2033.pdf

Size:

143.3Kb

Format:

PDF

Download

Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.

Star rating

Your vote was cast
Thank you for your feedback

Author

Roblin, P M
Kutlin, A
Hammerschlag, M R

Journal title

Antimicrobial agents and chemotherapy

Date Published

1997-09

Publication Volume

Publication Issue

Publication Begin page

2033

Publication End page

Metadata

Show full item record

URI

http://hdl.handle.net/20.500.12648/10343

Abstract

The in vitro susceptibilities of 12 strains of Chlamydia pneumoniae to a new quinolone, trovafloxacin, and ofloxacin, doxycycline, erythromycin, and azithromycin were determined. The activity of trovafloxacin was similar to that of ofloxacin, with a MIC at which 90% of the isolates are inhibited and a minimal concentration at which 90% of the isolates are killed of 1.0 microg/ml, but trovafloxacin was less active than doxycycline, erythromycin, and azithromycin.

Citation

Roblin PM, Kutlin A, Hammerschlag MR. In vitro activity of trovafloxacin against Chlamydia pneumoniae. Antimicrob Agents Chemother. 1997 Sep;41(9):2033-4. doi: 10.1128/AAC.41.9.2033. PMID: 9303410; PMCID: PMC164061.

Collections

Downstate College of Medicine

The following license files are associated with this item:

Creative Commons

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International